Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HSP90-IN-13 (compound 5k) is a potent broad-spectrum inhibitor of HSP90 with an IC50 of 25.07 nM. HSP90-IN-13 has multitargeted activity against EGFR, VEGFR-2 and Topoisomerase-2. HSP90-IN-13 blocks the MCF-7 cell cycle in G2/M HSP90-IN-13 blocks the MCF-7 cell cycle in G2/M phase and induces apoptosis through a mitochondria-mediated pathway.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | HSP90-IN-13 (compound 5k) is a potent broad-spectrum inhibitor of HSP90 with an IC50 of 25.07 nM. HSP90-IN-13 has multitargeted activity against EGFR, VEGFR-2 and Topoisomerase-2. HSP90-IN-13 blocks the MCF-7 cell cycle in G2/M HSP90-IN-13 blocks the MCF-7 cell cycle in G2/M phase and induces apoptosis through a mitochondria-mediated pathway. |
Molecular Weight | 483.54 |
Formula | C26H21N5O3S |
CAS No. | 2446055-29-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
HSP90-IN-13 2446055-29-2 inhibitor inhibit